Page 9 - Select Squeeze News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Once hush-hush affairs, cannabis-infused dinners are gaining popularity out in the open in Phoenix at venues like the Clarendon Hotel and Spa.

Author Bio After producing excellent results in Marketing Operations for over 16 years, and being a business owner prior to that, Jeff has developed a strong understanding of business success and a keen eye for data and detail. Combined with investing experience going back 30 years to his first investment in mutual funds, his knowledge and interests have led him to the role of a contract writer for The Motley Fool. 2021 is looking to be the year in which we find some normalcy and recovery. For Curaleaf Holdings (OTC:CURLF), a vertically integrated cannabis producer, ...

Author Bio Zhiyuan Sun is a statistician with a knack for analyzing clinical trials and company financials. Investing in healthcare and cannabis is his passion, as well as looking out for new, actionable stock investment ideas in these sectors. Fool since April 2020. Lives in Québec City, Canada. Follow @Bio_Chameleon The best growth stocks often appear expensive, no matter the market environment. That's why, when shares dip, investors get excited about a new buying opportunity.  Indeed,  Curaleaf Holdings (OTC:CURLF)(CNSX:CURA) are two companies that ap...

Pot Companies’ Hunt for New Markets Heats Up May 17 2021, 5:48 PM May 17 2021, 4:30 PM May 17 2021, 5:48 PM (Bloomberg) -- The cannabis land grab is getting more competitive. (Bloomberg) -- The cannabis land grab is getting more competitive. This was illustrated by Trulieve’s $2 billion acquisition of Harvest Health last week, which gives the company access to new states such as Maryland and Pennsylvania. The deal may give Trulieve an edge as it competes with the other major U.S. multistate operators, Green Thumb Industries and Curaleaf Holdings, which have also expanded to new stat...

May 13, 2021 at 6:12AM Curaleaf Holdings (OTC:CURLF) is a top multistate marijuana operator in the U.S., with 106 dispensaries and operations in 23 states. With an aggressive growth strategy and rapidly ascending sales numbers, it has captivated investors and been a popular option for those looking to tap into the industry's growth potential. But with a market cap of nearly $10 billion, has this licensed producer become too expensive to invest in today? Below I will look at its most recent quarterly earnings report, its future, and whether it's still a good buy. Image...